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Summary 
Recently we described the molecular cloning of SLP-76, a hematopoietic cell-specific 76-kD 
protein that was first  identified through its  association with GST/Grb2 fusion proteins. The 
primary sequence of SLP-76 predicts a protein of 533 amino acids comprising an amino-termi- 
nal region with numerous potential tyrosine phosphorylation sites, a central region rich in pro- 
line residues, and a single carboxy-terminal SH2 domain. Here we demonstrate formally that 
Grb2 associates  with unphosphorylated SLP-76 and map the Grb2 binding site on SLP-76 to 
amino acids 224-244. We also demonstrate that upon T cell receptor (TCR) stimulation, SLP- 
76 undergoes rapid tyrosine phosphorylation and associates  with tyrosine phosphoproteins of 
36, 62, and 130 kD. In vitro experiments show that the SH2 domain of SLP-76 associates with 
the 62- and 130-kD proteins and additionally with a serine/threonine kinase. Finally, we dem- 
onstrate that transient overexpression of SLP-76 results in dramatically enhanced TCR-medi- 
ated induction of nuclear factor of activated T  cells  (NFAT) and interleukin (IL) 2 promoter 
activity; and we provide evidence that a functional SLP-76 SH2 domain is required for this ef- 
fect. Our data document the in vivo associations of SLP-76 with several proteins that poten- 
tially participate in T  cell activation and implicate SLP-76 itself as an important molecule in 
TCR-mediated IL-2 production. 
L 
igation  of the  TCR  results in the  rapid  activation of 
several protein tyrosine kinases (PTKs) with the subse- 
quent phosphorylation of numerous cellular proteins (1-3), 
including components of the TCR itself (2, 3), Src and Syk 
family PTKs (Lck, Fyn, and ZAP-70 [for review see refer- 
ence  4]),  phospholipase  C~/1 (5-7),  GAP  (8),  ezrin  (9), 
CD5 (10, 11), Shc (12), Vav (13, 14), Cbl (15), and several 
cytoskeletal proteins (16). However, many substrates of the 
TCR-activated PTKs remain unidentified. Our laboratory 
has been interested in characterizing some of  these molecules. 
As  one  strategy,  we  chose  to  investigate  tyrosine  phos- 
phoproteins that associate with Grb2, an adapter molecule 
that has been shown to play a central role in coupling fig- 
naling pathways in other systems. 
Using this approach, we and others have demonstrated 
that tyrosine phosphoproteins of 36, 76, and 116 kD asso- 
ciate with  Grb2 in T  cells  (17-20).  The  116-kD protein 
has  been identified recently as  the  product  of the  c-Cbl 
protooncogene  (15);  however,  its  function  remains  un- 
clear. The molecular identity of the 36-kD protein remains 
uncertain, but recent data from our laboratory suggest that 
tyrosine phosphorylation of this  molecule is  required for 
coupling  the  TCK  with  the  phosphatidylinositol second 
messenger pathway (Motto, D., M. Musci, S. Ross, and G. 
Koretzky, manuscript submitted for publication). Recently, 
in a collaborative effort (Paul Findell, Palo Alto, CA), we 
purified  the  76-kD  Grb2-associated  phosphoprotein  and 
cloned its  cDNA,  which  encodes  a  novel hematopoietic 
cell-specific protein we have termed SLP-76, for S_H2 do- 
main leukocyte Erotein  of 76  kD  (21).  The primary se- 
quence  of SLP-76 predicts  a  protein of 533  amino  acids 
comprising an amino-terminal region with numerous po- 
tential tyrosine phosphorylation sites,  a central region rich 
in proline residues, and a single carboxy-terminal SH2 do- 
main.  Using  glutathione-S-transferase  (GST)/SLP-76  fu- 
sion proteins and deletion analysis,  we now have mapped 
the  Grb2 binding site on SLP-76 to  amino  acid residues 
224-244. Through the use of  specific antisera directed against 
SLP-76, we demonstrate that this molecule becomes rap- 
idly tyrosine phosphorylated after TCR stimulation and as- 
sociates  with  several additional  tyrosine phosphoproteins. 
Additionally,  in  vitro  experiments  demonstrate  that  the 
SH2 domain of SLP-76 associates  with a serine/threonine 
kinase  after  TCIL ligation.  Finally,  we  demonstrate  that 
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enhanced  TCR-mediated  induction  of the  nuclear factor 
of activated T  cells  (NFAT)  and  IL-2 promoter  activity. 
These results implicate SLP-76 as an important molecule in 
T  cell activation. 
Materials and Methods 
Cell Culture and Antibodies.  The humanJurkat T  cell line was 
maintained in RPMI 1640 supplemented with 10% FCS, penicil- 
fin (1,000 U/ml), streptomycin (1,000  U/ml), and glutamine (20 
raM).  The  following antibodies were  used  in  this study:  anti- 
TCR mAb C305 ([22]; gift of A. Weiss, University of California, 
San  Francisco,  CA);  anti-TCR  mAb  OKT3  (American  Type 
Culture  Collection, Rockville, MD);  antiphosphotyrosine mAb 
4G10 (gift of B. Drucker, University of Oregon, Pordand, OR); 
anti-Grb2 mAb (Upstate Biotechnology, Inc., Lake Placid, NY); 
and anti-flag mAb M2 (International Biotechnologies Inc., New 
Haven, CT). Anti-SLP-76 sheep antiserum 0083 was generated 
against amino  acids  136--235  of human  SLP-76  expressed as a 
GST fusion protein. For immunoprecipitation, the antiserum was 
conjugated to gamma bind plus Sepharose (Pharmacia, Uppsala, 
Sweden) and used at ~0.5 ~1/20 ￿  106 cell equivalents. The an- 
tiserum was used at 1:500 for Western blotting. 
cDNA Constructs and Fusion Proteins.  SLP-76 cDNA was am- 
plified by PCR using reverse-transcribed  Jurkat mRNA as a tem- 
plate. This cDNA, which was subcloned into pBluescript (Strat- 
agene Inc., La Jolla, CA) to generate the plasmid pBS/SLP-76/ 
myc, possesses a COOH-terminal myc epitope tag (EQKLISEEDL) 
and  a  silent  mutation  introducing  a  Hindlll  restriction site  at 
amino acids 229-230. SLP-76 cDNA with an NH2-terminal flag 
epitope tag (DYKDDDDK)  was generated by PCR using pBS/ 
SLP-76/myc  as  a  template  and  subcloned  into  the  pEF-BOS 
mammalian expression vector ([23];  gift ofD. Cantrell, Imperial 
Cancer Research Foundation, London, UK) to generate the plas- 
mid pEF/flag/SLP-76 WT. This SLP-76 cDNA no longer pos- 
sesses the  myc  COOH-terminal  epitope tag.  The  flag/SLP-76 
DNA encoding a deletion of amino acids 224-244 was generated 
by PCR  using flag/SLP-76 DNA as a template and subcloned 
into pEF-BOS to generate the plasnfid pEF/flag/SLP-76 A224- 
244.  SLP-76 DNA possessing the R448K mutation was gener- 
ated by overlap extension PCR  using pBS/SLP-76/myc cDNA 
as a template. This cDNA possesses a silent mutation introducing 
a  KpnI  restriction site  at  amino  acids 443-444.  The  resulting 
PCR product was subcloned into the plasmid pEF/flag/SLP-76 
WT after removal of the corresponding wild-type sequences, re- 
suiting in the plasmid pEF/flag/SLP-76 R448K. The GST/SLP- 
76 fusion proteins consisting of the indicated amino acids were 
generated by PCR  using reverse-transcribed Jurkat mRNA as a 
template and subcloned into either the pGEX-2TK or pGEX-3X 
bacterial expression vectors (Pharmacia). The GST/SLP-76 SH2 
domain possessing the loss-of-function R448K mutation was gen- 
erated by subcloning the overlap extension PCR product described 
above into  the  pGEX-3X  expression vector.  The  GST/Grb2, 
GST/Grb2  SH2,  and  GST/Grb2  SH2  R86K  constructs  were 
generated by PCR and subcloned into pGEX-2TK. GST fusion 
proteins were induced and affinity purified as described (24). 
Protein Precipitations and Immunoprecipitations.  For each experi- 
ment, Jurkat cells were left unstimulated or were stimulated with 
anti-TCR mAb (C305, ascites 1:1,000) for 1 rain unless otherwise 
noted.  Cell lysates prepared in NP-40  lysis buffer (1% NP-40, 
150 mM NaC1,  10 mM Tris, pH 7.4) including protease (50 p,g/ 
ml aprotinin, 10 p~g/rnl leupeptin, 50 ~g/ml pepstatin A, 1 mM 
PMSF) and phosphatase (400  nM sodium vanadate,  10 mM so- 
dium fluoride,  10  mM  sodium pyrophosphate) inhibitors were 
then  subjected to  precipitation with  the  indicated GST  fusion 
proteins or with the indicated antibodies for 2 h at 4~  Resulting 
protein complexes were then washed extensively in high salt lysis 
buffer (500  mM  NaC1),  resolved by SDS-PAGE, transferred to 
nitrocellulose, and  immunoblotted with  the  indicated mAb  or 
antisera, followed by a horseradish peroxidase-conjugated 2  ~ anti- 
body  (Bio-Rad  Laboratories,  Hercules,  CA).  Immunoreactive 
proteins  were  detected by  ECL  (Amersham  Corp.,  Arlington 
Heights, IL). 
In Vitro Kinase Assay and Phosphoamino Acid Analysis.  Follow- 
ing the  standard immunoprecipitation procedure,  samples were 
washed further in 500 mM LiC1, 5 mM Tris, pH 7.4, and once in 
water.  The  samples were  then  resuspended  in  kinase  reaction 
buffer (10 mM MnC12, 20 mM Tris, pH 7.4) plus [32p]~/ATP (10 
~Ci/sample) for 10 rain at room temperature, washed twice with 
water, subjected to SDS-8% PAGE, and visualized by autoradiog- 
raphy. The  ~100-kD  band was excised and subjected to phos- 
phoamino acid analysis as described (25). Briefly, the sample was 
rehydrated in 50 mM NH4HCO 3 and extracted twice with 0.1% 
SDS. The resulting supematants were then precipitated with 20{% 
TCA, acid hydrolyzed in 50  ~1 of 5.7 M  HC1 at  110~  for 10 
rain, and dried. The hydrolysate was then resuspended in running 
buffer (2.5% formic acid, 7.8% acetic acid, pH 1.9) with standards 
and subjected to TLC with a Hunter Thin Layer Electrophoresis 
System (CBS Scientific Co., Del Mar, CA). Standards were visu- 
alized with 0.25% ninhydrin, and the samples were detected by 
autoradiography. 
Transient Transfections and Luciferase Assays.  For transient trans- 
fections, log-phase Jurkat cells were electroporated with 40 ~g of 
the indicated plasmid construct in serum-free RPMI at a density 
of 107 cells/400 ~1 per cuvette with a gene pulser (Bio-Rad Lab- 
oratories) set at 250 V and 960 IxF. For transient transfections be- 
fore  luciferase assays, log-phase ]urkat  cells were  cotransfected 
with either 40 ~g of pEF/flag/SLP-76 plasmid or empty vector 
DNA,  plus  20  big of the  indicated  reporter  construct  (either 
NFAT-luc, gift of G.  Crabtree, Stanford University, Palo Alto, 
CA; or plL-21uc2kb, gift of R. Abraham, Mayo Clinic, Roches- 
ter, MN), in serum-free RPMI at a density of 107  cells/400 ~xl 
per cuvette with the conditions specified above. After electropo- 
ration, the cells were transferred to complete RPMI  and incu- 
bated at 37~  for 24 h. Triplicates of 5  ￿  105 viable cells were 
then stimulated as indicated for 8 h at 37~  and subsequently as- 
sayed for luciferase activity as described (26).  Briefly, cells were 
lysed in 100  Ixl luciferase lysis buffer (1% Triton X-100, 110 mM 
K2HPO4,  15 rnM KH2PO4,  5 mM dithiothreitol, pH 7.8)  for 10 
rain at room temperature. The lysate was then added to 100 txl of 
2X  luciferase assay buffer (220 mM K2HPO4, 30 mM KH2PO4, 
20 mM MgC12, 10 m/vl ATP, pH 7.8), and luciferase activity was 
quantitated with a luminometer (Monolight 2010; Analytical Lu- 
minescence  Laboratory, San Diego,  CA)  immediately after the 
addition of 100  p,1 of 1 mM luciferin (Sigma Chemical Co., St. 
Louis, MO). 
Results and Discussion 
Grb2 Assodates with SLP- 76  fiom Resting Cells.  Work  from 
our laboratory and others has demonstrated that Grb2 asso- 
1938  SLP-76 Augments TCR-mediated IL-2 Figure  1.  SLP-76 from resting and TCR-stimulated  T  cells associates 
with Grb2. NP-40 lysates of resting or TCR-stimulated  Jurkat  T  cells 
were precipitated with a full-length GST/Grb2 fusion protein (10 Wg fu- 
sion protein, 20 ￿  106 cell equivalents/condition), and the resulting pro- 
tein complexes were washed, resolved by SDS-10% PAGE, transferred to 
nitrocellulose, and immunoblotted with 4G10 antiphosphotyrosine mAb 
(A), or anti-SLP-76 antisera (B). The migrations of SLP-76, pp36, and 
pp116 (Cbl) are as indicated. The anti-SLP-76 antiserum was generated 
against a GST/SLP-76 fusion protein; therefore it also detects the GST/ 
Grb2 fusion protein in B. 
ciates with T  lymphocyte tyrosine phosphoproteins  of 36, 
76, and 116 kD, both in vitro and in vivo (Fig. 1 A  and ref- 
erences [17-20]).  Recently we purified the 76-kD protein 
and isolated its cDNA, which encodes a novel hematopoie- 
tic cell-specific protein of 533  amino acids we have named 
SLP-76  (21).  Specific  antisera  generated  against  SLP-76 
recognizes a 76-kD protein precipitated by GST/Grb2 from 
lysates of resting and TCR-stimulated Jurkat T  cells (Fig. 1 
B),  demonstrating  formally  that  the  association  between 
Grb2 and SLP-76 is independent of SLP-76 tyrosine phos- 
phorylation. 
Mapping of the Grb2-binding Site on SLP-76.  Previous  work 
has  demonstrated  that  the  association between  Grb2  and 
SLP-76 is mediated via one or both of the Grb2 SH3  do- 
mains  (17,  18).  We  therefore  reasoned  that  the  SLP-76 
Grb2-binding site most likely is located within the proline- 
rich central domain of SLP-76.  To map the Grb2-binding 
site within SLP-76, we subjected Jurkat cell lysates to pre- 
cipitation  with  several  GST/SLP-76  fusion  proteins  en- 
compassing the  central proline-rich domain  of this mole- 
cule (Fig. 2  A). As shown, the fusion proteins that contain 
SLP-76 amino acid residues 225-267 precipitate Grb2 (Fig. 
2 A, lanes 2-4), suggesting that the Grb2-binding site is lo- 
cated within  the  middle third of the  SLP-76  proline-rich 
domain.  In  confirmation  of this  finding,  fusion  proteins 
containing SLP-76 amino acids 225-265  also associate with 
Grb2 (Fig. 2  B, lanes  1 and 2). Removal of I> 10 amino ac- 
ids from  the  NH 2 terminus  of this  sequence  completely 
abrogates  Grb2  binding  (lanes  3-5),  demonstrating  that 
amino acids 225-235  of SLP-76 are required for its associa- 
tion with Grb2.  However these amino acids are not suftl- 
cient for Grb2 binding because the fusion protein consist- 
ing of SLP-76 amino acids 136-235  does not associate with 
Grb2 (Fig. 2 A, lane  1), suggesting that the amino acids im- 
Figure 2.  Mapping the Grb2-binding site on SLP-76 to amino acids 224-244. (A and B) GST/ 
SLP-76 fusion proteins consisting of the indicated SLP-76 amino acids were used to precipitate 
NP-40 lysates of unstimulated Jurkat cells. The resulting protein complexes were washed, re- 
solved by SDS-12% PAGE, transferred to nitrocellulose, and immunoblotted with anti-Grb2 
mAb. The GST/SLP-76 fusion proteins are depicted schematically  below each immunoblot. In 
B, the amino acid sequence below the schematic diagram represents SLP-76 amino acid residues 
225-265,  which  comprise  the  shortest GST/SLP-76  fusion  protein  that  binds  Grb2.  (C) 
Epitope-tagged SLP-76 with a deletion of amino acids 224-244  fails to associate with GST/ 
Grb2. Jurkat cells were transiently transfected with cDNA encoding either flag epitope-tagged 
wild-type SLP-76 or epitope-tagged SLP-76 possessing  a deletion of amino acids 224-244. After 
a 24-b incubation, NP-40 lysates  were prepared and subjected to precipitation with either anti- 
flag mAb (/eft) or GST/Grb2 (right). Resulting protein  complexes were washed, resolved by 
SDS-10% PAGE, transferred to nitrocellulose, and immunoblotted with anti-flag mAb. The mi- 
grations offlag/SLP-76 and flag/SLP-76 A224-244 are as indicated. 
1939  Motto et al.  Brief Definitive Report Figure 3.  SLP-76 becomes tyrosine phosphorylated and associates  with 
several additional proteins after TCR ligation. (A) Time course of TCR- 
induced SLP-76 tyrosine phosphorylation. Jurkat  T  cells were left un- 
stimulated or were stimulated with anti-TCR mAb for the lengths of 
time indicated. NP-40 lysates were then prepared and subjected to im- 
munoprecipitation with anti-SLP-76  antisera, and the resulting protein 
complexes were washed, resolved by SDS-8% PAGE, transferred to ni- 
trocellulose, and immunoblotted  with 4G10 antiphosphotyrosine mAb 
(top). Subsequently, the  immunoblot  was stripped and  reprobed  with 
anti-SLP-76 antisera (bottom). (B and C) SLP-76 associates  with several 
tyrosine phosphoproteins after TCtL ligation. NP-40 lysates of resting or 
TC1L-stimulated  Jurkat T cells were precipitated with either anti-SLP-76 
antisera (75 ￿  106 cell equivalents per condition) or the indicated GST/ 
SLP-76 SH2 domain fusion proteins (10 p.g fusion protein, 25 ￿  106 cell 
equivalents/condition), and the resulting protein complexes were washed, 
resolved by SDS-8% PAGE, transferred to nitrocellulose, and immuno- 
blotted with 4G10 antiphosphotyrosine mAb. The migratiomofSLP-76, 
pp36, pp62, and pp130 are as indicated. 
mediately  following  residue  235  also  contribute  to  the 
Grb2  binding  site.  In  support  of this  notion,  a  synthetic 
peptide composed of SLP-76 amino acid residues 229-246 
blocks the  association between  Grb2  and  SLP-76  in vitro 
(not  shown).  To  verify that  our  experiments  with  GST/ 
SLP-76 fusion proteins correctly localized the Grb2-binding 
site, we constructed and transiently expressed inJurkat cells 
cDNAs encoding epitope-tagged wild-type SLP-76 and an 
epitope-tagged  SLP-76  mutant  possessing  a  deletion  of 
amino acids 224-244  (Fig. 2  C). As shown,  although both 
of these  proteins  are  expressed  similarly,  only  the  wild- 
type molecule is precipitated by GST/Grb2, demonstrating 
Figure 4.  (A) In vitro kinase assay  of GST/SLP-76 SH2 domain fusion 
protein  precipitations.  NP-40  lysates of resting  or  TCR-stimulated 
(OKT3, ascites 1:1,000, 2 min)Jurkat T cells were precipitated with the 
indicated GST/SLP-76 SH2 domain fusion protein (10 I~g fusion protein, 
75 ￿  106 celt equivalents/condition), and the resulting protein complexes 
were washed and subjected to an in vitro kinase assay with 3zP-~/ATP. 
The resulting radiolabeled reaction products were then resolved by SDS- 
8% PAGE and detected by autoradiography. (B) Phosphoamino acid anal- 
ysis of the 100-kD phosphoprotein from A. The migrations of the phos- 
phoserine, phosphothreonine, and phosphotyrosine  standards  are as shown. 
(C) The serine/threonine kinase activity that associates  with the SH2 do- 
main of SLP-76 is not precipitated by the SH2 domain of Grb2. NP-40 
lysates ofpervanadate-stimulatedJurkat T cells were precipitated with the 
indicated GST/SH2 domain fusion protein (10 I~g fusion protein, 50 ￿ 
106 cell equivalents/condition), and the resulting protein complexes were 
washed and subjected to an in vitro kinase assay  with 32p-~ATP. The re- 
sulting radiolabeled reaction products  were  then  resolved by SDS-9% 
PAGE and detected by autoradiography. 
that  the  Grb2-binding  site  on  SLP-76  is  located  within 
amino acids 224-244. 
Tyrosine  Phosphorylation  Time  Course  and  Association  of 
SLP-76  with  Several Phosphoproteins after TCR  Stimulation. 
SLP-76  was  identified originally as  a  Grb2-associated ty- 
rosine phosphoprotein. To demonstrate formally that SLP-76 
is a substrate of  the TCR-activated PTKs, we subjected anti- 
SLP-76  immunoprecipitates  from  lysates  of resting  and 
TCl~.-stimulated Jurkat cells to antiphosphotyrosine West- 
em blotting (Fig. 3 A). As shown, SLP-76 undergoes an in- 
crease in tyrosine phosphorylation within 30 s of TCtL li- 
gation, which peaks by 1 min, and returns nearly to baseline 
by  60  min  of stimulation.  Additionally, when  increasing 
numbers  of  Jurkat cells are used,  tyrosine phosphoproteins 
of 36,  62,  and  130  kD  coimmunoprecipitate with SLP-76 
(Fig. 3 B). The 36-kD protein likely associates with SLP-76 
indirectly, via its association with  Grb2.  pp62  and  pp130 
interact with the  SH2  domain  of SLP-76  as demonstrated 
by their association with an SLP-76  SH2  domain GST fu- 
sion protein  (Fig.  3  C).  Mutation  of the  predicted phos- 
phate-binding arginine residue of the SLP-76 SH2 domain 
to  lysine  (R448K)  completely abrogates  binding  of pp62 
and  pp130,  suggesting that  the  association between  these 
molecules  is  dependent  on  tyrosine  phosphorylation  of 
pp62 andpp130 (Fig. 3  C). Western blotting of GST/SLP-76 
SH2  domain precipitations with antibodies against known 
1940  SLP-76 Augments TCR-mediated IL-2 Figure 5.  Overexpression of SLP-76 greatly augments TCR-mediated induction of NFAT and IL-2 promoter activity. (A)Jurkat cells were transiently 
cotransfected  with an NFAT-luciferase reporter construct together with either empty vector or epitope-tagged SLP-76 cDNA. The cells were then stim- 
ulated with media, anti-TCR mAb C305 (ascites  1:1,000), or C305 plus PMA (50 ng/ml) and subsequently assayed  for luciferase  activity. The results are 
expressed as the percentage of arbitrary luciferase  units (mean of triplicates)  induced by the stimulation condition compared with the maximal stimulation 
for each transfection condition induced by PMA (50 ng/ml) plus ionomycin (1 ~M) treatment. Maximal stimulations  for this experiment were "-'3 X 106 
light units for both transfection conditions. (B) Jurkat cells were transfected and analyzed as in A except the reporter construct used was IL-2 luciferase. 
Maximal stimulations were 2 X 106 light units for the empty vector transfection and 1.4 X 106 light units for the SLP-76 transfection. (C) A functional 
SH2 domain of SLP-76 is required for its ability to maximally augment TCR-mediated induction of  NFAT activity.  Jurkat cells  were transiently cotrans- 
fected with an NFAT-luciferase reporter construct together with either empty vector, epitope-tagged wild-type SLP-76 cDNA, or epitope-tagged SLP- 
76 cDNA possessing  the R448K mutation. The cells  were then stimulated with either media or anti-TCR mAb C305 (ascites  1:1,000) and analyzed as in 
A. Maximal stimulations were 0.9 X 106 light units for the empty vector transfection and 1.2 X 106 light units for the SLP-76 transfections.  In this exper- 
iment, 10 I~g more R448K than wild-type cDNA was transfected to ensure greater-than or equal-to expression of mutant protein compared with wild- 
type. (D) Expression levels of the SLP-76 constructs from C. NP-40 lysates (2 X 106 cell equivalents/condition) from each transfection condition were 
resolved  by SDS-8%  PAGE, transferred  to nitrocellulose,  and im-munoblotted  with anti-flag  mAb. The migrations of  the SLP-76 constructs  are as indicated. 
proteins of similar molecular mass demonstrates that pp62 is 
not p62/SAM,  and that pp130 is not Cbl, GAP, focal ad- 
hesion kinase (FAK), or p130  c^s (not shown). We are cur- 
renfly pursuing the identification of these molecules. 
To characterize further the properties of proteins that as- 
sociate with the SLP-76 SH2 domain, we subjected GST/ 
SLP-76  SH2  domain  fusion  protein  precipitations  from 
resting and TCR-stimulatedJurkat cell lysates to an in vitro 
kinase assay with  [32P]~/ATP  (Fig. 4  A). As shown,  TCR 
stimulation results in  increased protein kinase activity de- 
tected  in  the  wild-type  fusion  protein  precipitation  evi- 
denced by the increased phosphorylation of several protein 
species as indicated. Interestingly, when the phosphoprotein 
migrating at 0-~100 kid was excised and subjected to phos- 
phoamino  acid analysis, it was found to  contain phospho- 
serine and phosphothreonine, but not phosphotyrosine (Fig. 
4  B). This kinase activity appears to be specific for the SH2 
domain of SLP-76, as the  100-kD phosphoprotein was not 
detected  when  a  similar  experiment  was  performed  using 
GST/Grb2 SH2 domain fusion protein precipitations (Fig. 
4  C). As expected, the wild-type GST/Grb2  SH2  domain 
fusion protein associated with the previously described 36-kD 
tyrosine phosphoprotein  as demonstrated by antiphospho- 
tyrosine Western blotting (not shown):  These  results sug- 
gest that a serine/threonine kinase associates either directly 
or indirectly with the  SH2  domain  of SLP-76  after TCR 
stimulation. 
Overexpression  of SLP-76  Dramatically  Enhances  TCR- 
mediated NFAT and IL-2 Promoter Activity.  Our data dem- 
onstrating  that  SLP-76  becomes  tyrosine  phosphorylated 
after TCR  ligation, coupled with the observation that SLP- 
76 associates with several other potential signaling proteins, 
suggest  that  this  molecule plays a  role  in  TCR-mediated 
signal transduction.  One  important  consequence  of TCR 
ligation is the activation of the IL-2 gene, which is medi- 
ated in part by binding of transcription factors, such as NFAT, 
to the IL-2 promoter. To determine whether SLP-76 plays 
a  role in this process, we  investigated the  effect  of tran- 
sient SLP-76  overexpression on TCR-mediated induction 
of NFAT activity through the use of an NFAT-driven lu- 
ciferase reporter system (Fig. 5  A). As shown,  overexpres- 
sion  of SLP-76  greatly augments  NFAT  activity induced 
by both TCR  ligation and TCR  ligation plus phorbol ester 
stimulation. Western blotting ofceU lysates demonstrated that 
transient transfection of SLP-76 results in its overexpression 
by severalfold (not shown).  To  determine if SLP-76 over- 
expression augments transcription from the entire IL-2 pro- 
moter,  we  performed  a  similar  assay  using  instead  a  lu- 
ciferase reporter construct driven by 2  kb of IL-2 promoter 
sequence (Fig. 5  B). Similar to what was observed with the 
NFAT promoter, SLP-76 overexpression enhances IL-2 pro- 
moter activity induced by both TCR  and TCR  plus phor- 
bol ester stimulation. These data suggest that SLP-76 plays 
a  key role  in  linking the  TCR  with  an  important  distal 
event in T  cell activation. 
We  next investigated whether the  associations between 
SLP-76  and  molecules  that  bind  its  SH2  domain  are  re- 
quired  for  its  function  in  TCR-mediated  signaling.  As 
demonstrated above, the R448K mutation abrogates bind- 
ing of phosphotyrosine-containing proteins to the  SLP-76 
SH2  domain;  therefore  we  investigated the  effect  of this 
loss-of-binding mutation  on the ability of SLP-76 to  aug- 
1941  Motto et al.  Brief  Definitive Report ment  TCR-mediated  NFAT  activity.  As shown,  overex- 
pression of SLP-76 possessing the R448K mutation is much 
less effective at enhancing NFAT activity induced by TCR 
ligation when compared with wild-type SLP-76 (Fig. 5 C). 
That this effect is not due to lower level expression of the 
mutant  protein  was  confirmed  by  antiepitope  Western 
blotting  of cell lysates  (Fig  5  D).  These  data  demonstrate 
that a functional SH2 domain contributes to the ability of 
SLP-76 to participate in T  cell activation. 
SLP-76 was identified originally as a phosphoprotein that 
associates with Grb2 both in vitro and in vivo (17,  18, 21). 
In this report, we map the region of SLP-76 responsible for its 
association with Grb2 and demonstrate that this interaction 
is not dependent upon tyrosine phosphorylation. We show 
further that after TC1L stimulation, SLP-76 becomes rapidly 
tyrosine phosphorylated and associates in vivo with several 
unidentified  tyrosine phosphoproteins.  Two  of these pro- 
teins, pp62 and pp130, apparently bind the SH2 domain of 
SLP-76,  as  evidenced  by  their  association  with  a  GST/ 
SLP-76 SH2 domain fusion protein. Interestingly, the SLP-76 
SH2 domain also appears to bind a serine/threonine  kinase 
after TCR  ligation.  These  findings suggested that  SLP-76 
plays  an  important  role  in  linking  the  TCK  with  distal 
events in T  cell activation. We tested this hypothesis by as- 
sessing the effect ofSLP-76 overexpression on TCR.-medi- 
ated  induction  of NFAT  and  IL-2 promoter  activity and 
found that these important distal events of T  cell activation 
are  indeed  dramatically  enhanced  by SLP-76  overexpres- 
sion. We demonstrate further that this function of SLP-76 is 
at least partially dependent on its associations with molecules 
that  bind  its  SH2  domain,  as  overexpression  of SLP-76 
with  a  nonfunctional  SH2  domain  is  less  effective  at  en- 
hancing TC1L-mediated induction of NFAT activity than 
is  wild-type  SLP-76.  As these  events  in wild-type  T  cells 
require  the coordination of several signaling pathways, in- 
cluding  those  mediated  by PLC~I  and  Ras  (27-29),  it  is 
not  yet  clear  in  which  biochemical  pathway  SLP-76  is 
functioning.  Likewise,  it is not yet clear which features of 
SLP-76  are  necessary  for  its  function  in  these  processes. 
Now that we have identified regions of SLP-76 responsible 
for its associations with other potential signaling molecules, 
it will be possible to perform a detailed structure/function 
analysis of this molecule. Additionally, it will be important 
to  identify  tyrosine  phosphorylation  sites  of SLP-76  and 
determine their contribution to its function. These experi- 
ments  should help  to elucidate  further the role of SLP-76 
in the process of T  cell activation. 
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